VIgday
Register now by completing the form.

News

Publication of a guidance for the implementation of a self-checking system related to the installation and maintenance of medical devices used in the diagnosis and treatment of sleep apnea syndrome outside the hospital

Pursuant to the Royal Decree of 24 October 2024, the FAMHP has approved a guide explaining in detail all the aspects that actors in the service and technical home assistance (STHA) sector must take into account to correctly set up a self-checking system. This guide includes a set of obligations.

Notification procedure for advertising of medicinal products for veterinary use to the public

On 1 January 2025, the Royal Decree of 22 September 2024 on advertising of medicinal products for veterinary use will come into force. That Decree describes the mandatory notification procedure prior to the distribution of any advertisement for a medicinal product for veterinary use to the general public.

Significant increase in the number of Belgians who have registered their will to make a donation of human body material in 2023

The Orgadon annual report provides quantitative data on the donation of human body material in Belgium since 2020. In 2023, the number of declarations of explicit consent increased considerably, while the number of declarations of opposition showed a slight increase.

Limited availability of intravenous infusion fluids: recommendations for physicians (specialists) and (hospital) pharmacists

The Federal Agency for Medicines and Health Products (FAMHP) was notified on 15 October 2024, by the company Baxter of the limited availability of certain infusion fluids for intravenous (IV) administration until 31 December 2024. Indeed, Baxter's largest manufacturing facility in North Cove (North Carolina, United States of America) was severely affected by Hurricane Helene.